Technetium (99mTc) votumumab
From WikiMD's WELLNESSPEDIA
| Technetium (99mTc) votumumab | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | not marketed |
| CAS Number | 148189-70-2 |
| PubChem | |
| DrugBank | |
| ChemSpider | none |
| KEGG | |
Technetium (99mTc) votumumab (trade name HumaSPECT) is a human monoclonal antibody labelled with the radionuclide technetium-99m.[1] It was developed for the detection of colorectal tumors, but has never been marketed.[2]
The target of votumumab is CTAA16.88, a complex of cytokeratin polypeptides in the molecular weight range of 35 to 43 kDa, which is expressed in colorectal tumors.[3]
References[edit]
| Diagnostic radiopharmaceuticals (V09) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
 | This medical article is a stub. You can help WikiMD by expanding the page. |
